Does it matter how we measure urinary creatinine in patients taking SGLT2 inhibitors?

Nephrol Dial Transplant. 2024 Apr 26;39(5):739-741. doi: 10.1093/ndt/gfae007.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Creatinine* / urine
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / urine
  • Glomerular Filtration Rate
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Creatinine
  • Hypoglycemic Agents